BamSEC and AlphaSense Join Forces
Learn More

Theralink Technologies Inc

Formerly OTC: THER
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-Q 6 pages Theralink Technologies, Inc. 2023 Convertible Secured Promissory Note
12/34/56
EX-4.3
from 8-K 26 pages 10.0% Original Issue Discount Senior Secured Convertible Debenture Due November 29, 2023
12/34/56
EX-4.2
from 8-K 21 pages Common Stock Purchase Warrant Theralink Technologies, Inc
12/34/56
EX-4.1
from 8-K 26 pages 10.0% Original Issue Discount Senior Secured Convertible Debenture Due [___]1, 2023
12/34/56
EX-4.2
from 10-Q 11 pages Common Stock Purchase Warrant Theralink Technologies, Inc
12/34/56
EX-4.1
from 10-Q 9 pages Theralink Technologies, Inc. 2022 Convertible Promissory Note
12/34/56
EX-4.3
from 8-K 13 pages Common Stock Purchase Warrant Theralink Technologies, Inc
12/34/56
EX-4.2
from 8-K 10 pages Common Stock Purchase Warrant Theralink Technologies, Inc
12/34/56
EX-4.1
from 8-K 10 pages Theralink Technologies, Inc. 2021 Convertible Promissory Note
12/34/56
EX-4.1
from 8-K 10 pages Common Stock Purchase Warrant Theralink Technologies, Inc
12/34/56
EX-4.2
from 8-K 9 pages Common Stock Purchase Warrant Theralink Technologies, Inc
12/34/56
EX-4.1
from 8-K 8 pages Theralink Technologies, Inc. 2021 Convertible Secured Promissory Note
12/34/56
EX-4.2
from 8-K 9 pages Common Stock Purchase Warrant Oncbiomune Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 12 pages Common Stock Purchase Warrant Oncbiomune Pharmaceuticals, Inc
12/34/56
EX-4.1
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 10-Q 14 pages Common Stock Purchase Warrant Oncbiomune Pharmaceuticals, Inc
12/34/56
EX-4.1
from 10-Q 19 pages 10% Original Issue Discount 5% Senior Convertible Note Due May 25, 2020
12/34/56
EX-4.2
from 8-K 15 pages Common Stock Purchase Warrant Oncbiomune Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 20 pages 10% Original Issue Discount 5% Senior Convertible Note Due February 3, 2020
12/34/56